LPC
Lion Point Capital Portfolio holdings
AUM
$14.7M
This Quarter Return
-2.14%
1 Year Return
+16.78%
3 Year Return
+52.25%
5 Year Return
+189.95%
10 Year Return
–
AUM
$109M
AUM Growth
+$109M
(-19%)
Cap. Flow
-$19.2M
Cap. Flow
% of AUM
-17.57%
Top 10 Holdings %
Top 10 Hldgs %
91.03%
Holding
36
New
5
Increased
3
Reduced
5
Closed
5
Top Buys
| 1 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$824K |
| 2 |
Travere Therapeutics
TVTX
|
$697K |
| 3 |
Humacyte
HUMA
|
$689K |
| 4 |
Replimune Group
REPL
|
$599K |
| 5 |
Insmed
INSM
|
$505K |
Top Sells
| 1 |
Chord Energy
CHRD
|
$15.7M |
| 2 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$1.51M |
| 3 |
Ardelyx
ARDX
|
$1.43M |
| 4 |
TSVT
2seventy bio
TSVT
|
$1.13M |
| 5 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$903K |
Sector Composition
| 1 | Technology | 57.83% |
| 2 | Healthcare | 20.69% |
| 3 | Consumer Discretionary | 2.91% |
| 4 | Energy | 2.16% |
| 5 | Communication Services | 0.01% |
